Concomitant chemoradiotherapy in adult malignant glioma;Chimioradiotherapie concomitante et tumeurs gliales malignes de l'adulte

Cancer/Radiotherapie

Volumn 2, Issue 6, 1998, Pages 672-678

  Honnorat, J ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Concomitant chemoradiotherapy; Malignat glioma

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; CARBOPLATIN; CARMUSTINE; CISPLATIN; FLUOROURACIL; HYDROXYUREA; METRONIDAZOLE; MITOLACTOL; MITOMYCIN; PACLITAXEL; TAMOXIFEN; TENIPOSIDE; RADIOSENSITIZING AGENT;

BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; NEUROTOXICITY; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION NECROSIS; REVIEW; ADJUVANT CHEMOTHERAPY; ADULT; BRAIN TUMOR; GLIOMA; MORTALITY; MULTIMODALITY CANCER THERAPY; SKULL IRRADIATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; GLIOMA; HUMANS; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032248225     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(99)80007-9     Document Type: Article

References (46)

1. 1 Ben-Hassel M, Lesimple T, Gedouin D, Chenal C, Guegan Y, Darcel F. Unusual combination of cis platinum and radiotherapy followed by a three fractions per day irradiation in splitcourse: a phase I-II study in brain glioma patients. Strahlenteher Onkol 1992 ; 168 : 502-12
2. 2 Blechen NM, Stenning SP and behalf of the medical research council brain tumor working party. A medical research council trial of two radiotherapy doses in the treatment of grade 3 and 4 astrocytoma. B J Cancer 1991 ; 64 : 769-74
3. 3 Boiardi A, Silvani A, Pozzi A, Farinotti M, Fariselli L, Broggi G et al. Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. J Neuro Oncol 1997 ; 34: 179-85
4. 4 Brandes AA, Rigon A, Zampieri P, Ermani M, Carollo C, Altavilla G. Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme. Cancer 1998 ; 82 : 355-61
5. 5 Brandes AA, Rigon A, Zampieri P, Scelzi E, Amista P, Berti F et al. Early chemotherapy and concurrent radio-chemotherapy in high grade glioma. J Neuro Oncol 1996 ; 30 : 247-55
6. 6 Cairncross JG, MacDonald DR, Ludwin S, Lee D, Cascino T, Buckner J et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994 ; 12 : 2013-21
7. 7 Cairncross JG, MacDonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988 ; 23 : 360-4
8. 8 Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983 ; 52 : 997-1007
9. 9 Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 1993 ; 85 : 704-10
10. 10 Davis LW. Presidential address: malignant glioma - a nemesis which requires clinical and basic investigation in radiation oncology. Int J Radiat Oncol Biol Phys 1989 ; 16 : 1355-65
11. 11 EORTC Brain Tumour Group. Mizonidazole in radiotherapy of supratentorial malignant gliomas in adult patients: a randomized double-blind study. Eur J Cancer Clin Oncol 1983 ; 19 : 39-42
12. 12 EORTC Brain Tumour Group. Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. Europ J Cancer 1991 ; 27 : 568-70
13. 13 Feun LG, Stewart DJ, Maor M, Leavens M, Savaraj N, Burgess MA et al. A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas. J Neuro Oncol 1983 ; 1 : 109-13
14. 14 Fine HA, Dear KBG, Loeffler JS, Black P, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993 ; 71 : 2585-97
15. 15 Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry-Amar M, Raverdy N et al. Descriptive epidemiology of cerebral gliomas in France, Cancer 1997 ; 79 : 1195-202
16. 16 Forsyth PA, Cairncross JG. Chemotherapy for malignant gliomas. Vol 5. N° 2, London: Baillière Tindall; 1996. p 371-93
17. 17 Fountzilas G, Karavelis A, Makrantonakis P, Selviaridis P, Tzitzikas J, Kalogera-Fountzila A et al. Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas: a feasibility study. Am J Clin Oncol 1997 ; 20 : 138-42
18. 18 Glass J, Hochberg FH, Gruber ML. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992 ; 76 : 741-5
19. 19 Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67 : 121-32
20. 20 Greenberg HS, Chandler WF, Ensminger WD, Sandler H, Junck L, Page MA et al. Radiosensitization with carotid intra-arterial bromodeoxyuridine ± 5-fluorouracil biomodulation for malignant gliomas. Neurology 1994 ; 44 : 1715-20
21. 21 Halperin EC, Herndon J, Schold SC, Brown M, Vick N, Cairncross JG et al. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. Int J Radiat Oncol Biol Phys 1996 ; 34 : 793-802
22. 22 Hildebrand J, Sahmoud T, Mignolet F, Brucher JM, Afra D. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. Neurology 1994 ; 44 : 1479-83
23. 23 Jeremic B, Grujicic D, Antunovic V, Ljubodrag D, Stojanovic M, Shibamoto Y. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study. Int J Radiat Oncol Biol Phys 1994 ; 30 : 1179-85
24. 24 Kiu MC, Chang CN, Cheng WC, Lin TK, Wong CW, Tang SG et al. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas. J Neuro Oncol 1995 ; 25 : 215-20
25. 25 Krishnasamy S, Vokes EE, Dohrmann GJ, Mick R, Garcia JC, Kolker JD et al. Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest 1995 ; 13 : 453-9
26. 26 Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the scandinavian glioblastoma study group. Cancer 1981 ; 47 : 649-52
27. 27 Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993 ; 32 ; 365-71
28. 28 Lange OF, Haase KD, Scheef W. Simultaneous radio- and chemotherapy of inoperable brain tumors. Radiother Oncol 1987 ; 8 : 309-14
29. 29 Lederman G, Arbit E, Odaimi M, Lombardi E, Wrzolek M, Wronski M. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. Int J Radiat Oncol Biol Phys 1998 ; 40 : 661-6
30. 30 Levin VA, Maor MH, Thall PF, Yung WKA, Bruner J, Sawaya R et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1995 ; 33 : 357-64
31. 31 Malkin MG, Green SB, Byar DP, Stike TA, Burger PC, Vogel FS et al. Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group. J Neuro Oncol 1994 ; 22 : 55-65
32. 32 Mason WP, Krol GS, DeAngelis LM. Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996 ; 46 : 203-7
33. 33 Napolitano M, Keime-Guibert F, Lafitte C, Ameri A, Cornu P, Delattre JY. Treatment of supratentorial glioblastomas multiforme with the association of BCNU and low or high dose of tamoxifen: a phase II study [abstract]. Neurology 1998 ; 50 : A352
34. 34 Perry JR. Adjuvant chemotherapy for malignant glioma: an analysis of methodology and outcome data from clinical trials [abstract]. Neurology 1995 ; 45 : A386
35. 35 Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB et al. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a northern California cancer center phase II study. Int J Radiat Oncol Biol Phys 1991 ; 21 : 709-14
36. 36 Poisson M, Pouillard P, Pertuiset BF. La chimiothérapie des glioblastomes. Encycl Méd Chir (Elsevier, Paris). Neurologie, 17-305-B-10. 1982 : 6 p
37. 37 Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM et al. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys 1998 ; 40 : 57-63
38. 38 Rutten E, Doesburg H, Slooff L. Histologic factors in the grading and prognosis of astrocytoma grade I-IV. J Neuro Oncol 1992 ; 13 : 223-30
39. 39 Sandberg-Wollheim M, Malmström P, Strömblad LG, Anderson H, Borgström S, Brun A et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 1991 ; 68 : 22-9
40. 40 Scheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980 ; 6 : 1215-28
41. 41 Urtasun RC, Cosmatos D, DelRowe J, Kinsella TJ, Lester S, Wasserman T et al. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12). Int J Radiat Oncol Biol Phys 1993 ; 27 : 207-14
42. 42 Vigliani MC, YaYa-Tur R, Delattre JY. Combined radiation and chemotherapy-induced disorders of the brain and spinal cord. In: Vecht CJ, eds. Handbook of Clinical Neurology: Neuro-Oncology, Part I. Amsterdam: Elsevier Science BV; 1997. p 353-70
43. 43 Vokes EE, Wechselbaum R. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990 ; 8 : 911-34
44. 44 Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neursurg 1978 ; 49 : 333-43
45. 45 Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH et al. Randomized comparisons of radiotherapy and nitrosources for the treatment of malignant glioma after surgery. New England J Med 1980 ; 303 : 1323-9
46. 46 Winger MJ, MacDonald DR, Cairncross JG. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low grade glioma. J Neurosurg 1989 ; 71 : 487-93